EURO-MED LABORATORIE

EURO
End-of-day quote. End-of-day quote  - 11/26
1.55PHP +3.33%
Valuation
Fiscal Period: December 2019 2020
Capitalization1 6 5799 622
Entreprise Value (EV)1 9 15612 481
P/E ratio 17,8x46,8x
Yield 3,13%-
Capitalization / Revenue 1,16x2,51x
EV / Revenue 1,16x2,51x
EV / EBITDA 6,57x12,6x
Price to Book 1,21x1,77x
Nbr of stocks (in thousands) 4 112 1414 112 141
Reference price (PHP) 1,602,34
Announcement Date 04/30/202104/30/2021
Previous period Next period
1 PHP in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 5 6883 829
EBITDA1 1 002763
Operating profit (EBIT)1 761541
Operating Margin 13,4%14,1%
Pre-Tax Profit (EBT)1 557305
Net income1 389210
Net margin 6,84%5,49%
EPS2 0,090,05
Dividend per Share2 0,05-
Announcement Date 04/30/202104/30/2021
Previous period Next period
1 PHP in Million
2 PHP
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt 2 5772 859
Net Cash position --
Leverage (Debt / EBITDA) 2,57x3,75x
Free Cash Flow1 17,1-80,7
ROE (Net Profit / Equities) 7,20%3,85%
Shareholders' equity1 5 4025 452
ROA (Net Profit / Asset) 4,75%3,31%
Assets1 8 1816 343
Book Value Per Share 1,331,32
Cash Flow per Share 0,270,12
Capex1 582451
Capex / Sales 10,2%11,8%
Announcement Date 04/30/202104/30/2021
Previous period Next period
1 PHP in Million
Price Earning Ratio
Year-on-year evolution of the Yield
EPS & Dividend